Quarterly ResultAug 6, 2026, 04:48 PM
SANUWAVE Health Reports Q2 Net Loss of $0.68M; H1 Net Loss Narrows
AI Summary
SANUWAVE Health, Inc. reported a net loss of $0.68 million for Q2 2026, a shift from a net income of $0.55 million in the prior year's quarter. For the first six months of 2026, the company's net loss narrowed to $2.12 million from $5.57 million in H1 2025, despite a slight revenue decrease to $19.36 million. Operating cash flow significantly improved, turning positive at $0.82 million for H1 2026. The company also continued to address previously disclosed restatements related to sales tax liabilities and warranty accounting.
Key Highlights
- Reported Q2 2026 net loss of $0.68 million, compared to net income of $0.55 million in Q2 2025.
- H1 2026 net loss narrowed to $2.12 million from $5.57 million in H1 2025.
- Q2 2026 revenue was $9.74 million, a slight decrease from $10.05 million in Q2 2025.
- H1 2026 revenue was $19.36 million, a slight decrease from $19.39 million in H1 2025.
- Net cash provided by operating activities was $0.82 million in H1 2026, up from $(0.52) million used in H1 2025.
- Repaid $2.88 million of the secured term loan principal during H1 2026.
- Restated Q2 2025 financials due to sales tax liabilities and warranty accounting errors.
- Modified headquarters lease, increasing ROU asset and lease liability by $0.6 million.
Price Impact
More from SNWV